Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Our friend and partner, Narjust (N.J.) Duma, MD is a Chief Hematology/Medical Oncology Fellow at Mayo Clinic in Rochester, MN. Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
N.J. speaks to cancer myths in the Latino community, and in this video N.J. discusses Alternative Medicine in Cancer. Stay tuned for more great videos!
Our friend and partner, Narjust (N.J.) Duma, MD is a Chief Hematology/Medical Oncology Fellow at Mayo Clinic in Rochester, MN. Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
N.J. speaks to cancer myths in the Latino community, and in this video N.J. discusses 3 common myths about breast cancer. Stay tuned for more great videos!
Our friend and partner, Narjust (N.J.) Duma, MD is a Chief Hematology/Medical Oncology Fellow at Mayo Clinic in Rochester, MN. Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
Hi Grace Members,
Grace is happy to present in partnership with the Swedish Cancer Institute "Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?" this Saturday, November 10, 2018 | 10:00 am– 1:00 pm Pacific time. This seminar will be available at no charge in person and as a live webinar.
Hi Grace Members,
Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?" this Saturday, November 10, 2018 | 10:00 am– 1:00 pm Pacific time. This seminar will be available at no charge in person and as a live webinar.
Hello Grace Members,
We are happy to introduce a new partnership with Clinical Care Options to help people better understand treatment options for those just diagnosed with follicular lymphoma. This is the first of several such tools. Other cancer decision making tools CCO will produce in the coming year include decision making tools include early breast cancer and NSCLC.
The Global Resource for Advancing Cancer Education (GRACE), presents Molecular Diagnostic Testing and Next Generation Sequencing in Lung Cancer webinar series.
PET stands for “positron emission tomography”, and a PET scan is a procedure designed to identify abnormal cellular activity that might indicate cancer. A prominent use for the PET scan (or combination PET/CT) is in achieving accurate staging of cancer.
Nathan Pennell, MD, PhD , Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses Liquid Biopsies for Broad Genomic Testing in Lung Cancer.
Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses optimal follow up for patients after resection of an early-stage non-small cell lung cancer (NSCLC).
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.